Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

This study will evaluate the safety and efficacy of botulinum toxin type A compared to placebo for the treatment of Crow's Feet Lines and Frown Lines (Facial Rhytides) for patients who successfully completed Study 191622-099.

Inclusion Criteria:

• Successfully completed Study 191622-099

Exclusion Criteria:

• Known immunization or hypersensitivity to botulinum toxin of any serotype
• Anticipated need for treatment with botulinum toxin of any serotype during the study (except for study treatment)
• Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, or amyotrophic lateral sclerosis
• Anticipated need for surgery or hospitalization during the study